Literature DB >> 11244022

Restoration of nitric oxide availability after calcium antagonist treatment in essential hypertension.

S Taddei1, A Virdis, L Ghiadoni, A Magagna, S Favilla, A Pompella, A Salvetti.   

Abstract

Essential hypertension is associated with impaired endothelium-dependent vasodilation caused by oxygen free radical-induced nitric oxide (NO) breakdown. Because calcium antagonists can improve endothelial function in patients with essential hypertension, in this study we tested the hypothesis that this beneficial effect could be related to restoration of NO availability by antioxidant properties. In 15 healthy subjects and 15 hypertensive patients, we studied forearm blood flow (strain-gauge plethysmography) modifications induced by intrabrachial acetylcholine (ACh; 0.15, 0.45, 1.5, 4.5, and 15 microg/100 mL per minute), an endothelium-dependent vasodilator in basal conditions, during infusion of N:(G)-monomethyl-L-arginine (L-NMMA, 100 microg/100 mL forearm tissue per minute), an NO-synthase inhibitor, vitamin C (8 mg/100 mL forearm tissue per minute), and finally, simultaneous infusion of L-NMMA and vitamin C. The response to sodium nitroprusside (SNP; 1, 2, and 4 microg/100 mL forearm tissue per minute) was also evaluated. In control subjects, vasodilation to ACh was inhibited by L-NMMA and not changed by vitamin C. In hypertensive patients, vasodilation to ACh was blunted as compared with control subjects and resistant to L-NMMA. Vitamin C, which decreased plasma isoprostanes and increased plasma antioxidant capacity, increased the response to ACh and restored the inhibiting effect of L-NMMA. In hypertensive patients, the study was repeated after 3-month treatment with nifedipine gastrointestinal therapeutic system (30 to 60 mg/daily). Nifedipine treatment decreased circulating plasma lipoperoxides and isoprostanes and increased plasma antioxidant capacity. Moreover, nifedipine increased the vasodilation to ACh but not to SNP and restored the inhibiting effect of L-NMMA on ACh-induced vasodilation, whereas vitamin C no longer exerted its facilitating activity. These results indicate that nifedipine increases endothelium-dependent vasodilation by restoring NO availability, an effect probably determined by antioxidant activity.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11244022     DOI: 10.1161/01.hyp.37.3.943

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  28 in total

Review 1.  Effects of antihypertensive drugs on endothelial dysfunction: clinical implications.

Authors:  Stefano Taddei; Agostino Virdis; Lorenzo Ghiadoni; Isabella Sudano; Antonio Salvetti
Journal:  Drugs       Date:  2002       Impact factor: 9.546

2.  Effects of antihypertensive treatment on endothelial function.

Authors:  Agostino Virdis; Lorenzo Ghiadoni; Stefano Taddei
Journal:  Curr Hypertens Rep       Date:  2011-08       Impact factor: 5.369

3.  Gene-gene interactions in the NAMPT pathway, plasma visfatin/NAMPT levels, and antihypertensive therapy responsiveness in hypertensive disorders of pregnancy.

Authors:  M R Luizon; A C T Palei; V A Belo; L M Amaral; R Lacchini; G Duarte; R C Cavalli; V C Sandrim; J E Tanus-Santos
Journal:  Pharmacogenomics J       Date:  2016-05-10       Impact factor: 3.550

4.  Comparison of lercanidipine plus hydrochlorothiazide vs. lercanidipine plus enalapril on micro and macrocirculation in patients with mild essential hypertension.

Authors:  Carolina De Ciuceis; Massimo Salvetti; Anna Paini; Claudia Rossini; Maria Lorenza Muiesan; Sarah Duse; Stefano Caletti; Maria Antonietta Coschignano; Francesco Semeraro; Valentina Trapletti; Fabio Bertacchini; Valeria Brami; Alina Petelca; Enrico Agabiti Rosei; Damiano Rizzoni; Claudia Agabiti Rosei
Journal:  Intern Emerg Med       Date:  2017-06-24       Impact factor: 3.397

5.  Increased blood flow induces oxidative stress through an endothelium- and nitric oxide-independent mechanism.

Authors:  Pete Fong; Diana M Stafforini; Nancy J Brown; Mias Pretorius
Journal:  Free Radic Biol Med       Date:  2010-04-24       Impact factor: 7.376

Review 6.  Current therapeutic strategies to mitigate the eNOS dysfunction in ischaemic stroke.

Authors:  Kirtiman Srivastava; Philip M W Bath; Ulvi Bayraktutan
Journal:  Cell Mol Neurobiol       Date:  2011-12-25       Impact factor: 5.046

Review 7.  Drug Treatment of Hypertension: Focus on Vascular Health.

Authors:  Alan C Cameron; Ninian N Lang; Rhian M Touyz
Journal:  Drugs       Date:  2016-10       Impact factor: 9.546

Review 8.  Current treatment of patients with hypertension: therapeutic implications of INSIGHT.

Authors:  Stefano Taddei; Lorenzo Ghiadoni; Antonio Salvetti
Journal:  Drugs       Date:  2003       Impact factor: 9.546

Review 9.  Combined antihypertensive and lipid-lowering treatment.

Authors:  Maurizio Cesari; Achille C Pessina
Journal:  Curr Hypertens Rep       Date:  2004-08       Impact factor: 5.369

Review 10.  Potential mechanisms of impaired endothelial function in arterial hypertension and hypercholesterolemia.

Authors:  Stefan John; Roland E Schmieder
Journal:  Curr Hypertens Rep       Date:  2003-06       Impact factor: 5.369

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.